LFG
MRVI icon

Larson Financial Group’s Maravai LifeSciences MRVI Stock Holding History

Larson Financial Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,880
Closed -$15.7K – 3160
2024
Q4 		$15.7K Buy
2,880
+1,477
+105% +$9.5K ﹤0.01% 1311
2024
Q3 		$11.7K Buy
+1,403
New +$12.1K ﹤0.01% 1422

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Larson Financial Group's MRVI Position: Q1 2025 in Review

Larson Financial Group sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 2,880 shares — an estimated $15.7K sold.

Larson Financial Group first reported a position in MRVI in Q3 2024 and held it in 2 quarters. The position peaked at $15.7K in Q4 2024. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

  • Larson Financial Group reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Larson Financial Group sold 2,880 Maravai LifeSciences shares in Q1 2025, an estimated $15.7K.
  • Larson Financial Group first reported a position in Maravai LifeSciences in Q3 2024 and held it in 2 quarters.
  • Larson Financial Group's Maravai LifeSciences position peaked at $15.7K in Q4 2024.
  • 184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Larson Financial Group's 13F filing for Q1 2025, filed 2 May 2025.